|
RWDD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.603600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.680800E-01 |
| Normal-vs-Stage2 |
7.965000E-01 |
| Normal-vs-Stage3 |
4.318000E-01 |
| Normal-vs-Stage4 |
9.534600E-01 |
| Stage1-vs-Stage2 |
9.096400E-01 |
| Stage1-vs-Stage3 |
5.736800E-01 |
| Stage1-vs-Stage4 |
7.762000E-01 |
| Stage2-vs-Stage3 |
8.387400E-01 |
| Stage2-vs-Stage4 |
7.792200E-01 |
| Stage3-vs-Stage4 |
4.657400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.347600E-01 |
| Normal-vs-AfricanAmerican |
7.546200E-02 |
| Normal-vs-Asian |
2.463800E-01 |
| Caucasian-vs-AfricanAmerican |
1.353840E-02 |
| Caucasian-vs-Asian |
3.433800E-01 |
| AfricanAmerican-vs-Asian |
9.696800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.475900E-02 |
| Normal-vs-Female |
8.034100E-02 |
| Male-vs-Female |
2.590500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.984600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.551400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.571600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.189800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.202200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.373200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.419800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.720800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.019800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.281400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.743850E-01 |
| Normal-vs-Grade 2 |
2.672800E-01 |
| Normal-vs-Grade 3 |
5.374300E-02 |
| Normal-vs-Grade 4 |
3.228600E-01 |
| Grade 1-vs-Grade 2 |
4.336600E-01 |
| Grade 1-vs-Grade 3 |
1.648050E-02 |
| Grade 1-vs-Grade 4 |
5.883900E-02 |
| Grade 2-vs-Grade 3 |
2.499100E-03 |
| Grade 2-vs-Grade 4 |
6.168100E-02 |
| Grade 3-vs-Grade 4 |
6.264200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.579000E-01 |
| Normal-vs-ccB subtype |
4.522200E-02 |
| ccA subtype-vs-ccB subtype |
1.133850E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.594200E-01 |
| Normal-vs-N1 |
1.278800E-01 |
| N0-vs-N1 |
1.785570E-01 |
|
|
